Financials
AFSA was semi-dormant for a few years, but in 2023 we decided to kick the organization into high gear. While the number of medical journal reports on fibromyalgia continues to grow, most of the focus has been headed in the wrong direction. Patients don’t need more hyped-up studies about the marvels of exercise and behavioral therapies, they need (and deserve) more investigations that will significantly impact their care.
Fibromyalgia research must be redirected toward patient needs, such as improved treatments, objective biomarkers, and a better understanding of what causes this disease. AFSA’s small research grants program is essential for steering studies in the direction of patient-relevant projects.
In November of 2023, AFSA announced its request for applications (RFA) to over 50 investigative teams whose areas of study are aligned with our research-funding mission. We hope to award up to five grants ($85,000 each) by the end of August 2024.
While the 2023 RFA will trim our cash reserves by 40 percent, we plan to engage in active fundraising so that we can continue to award multiple grants each year. In the meantime, we are happy to share with you graphs of our asset balances and financial summaries for the past three years. If you would like to download our IRS Form 990 for our last three fiscal years, they are available below as PDFs.
